Volume 16, Number 2—February 2010
Research
Imported Methicillin-Resistant Staphylococcus aureus, Sweden
Table 3
Country | No. adoptions | No. with MRSA acquisition (no. with MRSA disease) | Risk/1,000 adoptions (95% CI) |
---|---|---|---|
The Philippines | 27 | 2 (0) | 74.1 (9.1–242.8) |
South Korea | 467 | 14 (0) | 30.0 (16.5–49.8) |
Bulgaria | 91 | 2 (1) | 22.0 (2.7–77.1) |
Belarus | 174 | 3 (1) | 17.2 (3.6–49.6) |
Russia | 263 | 4 (0) | 15.2 (4.2–38.5) |
Ethiopia | 71 | 1 (1) | 14.1 (0.4–76.0) |
Ukraine | 74 | 1 (0) | 13.5 (0.3–73.0) |
People’s Republic of China | 1,074 | 7 (3) | 6.5 (2.6–13.4) |
Colombia | 460 | 3 (0) | 6.5 (1.3–18.9) |
South Africa | 154 | 1 (0) | 6.5 (0.16–35.6) |
India | 243 | 1 (0) | 4.1 (0.1–22.7) |
Vietnam | 328 | 1 (0) | 3.0 (0.1–16.8) |
Other countries |
743 |
0 |
– |
Total | 4,169 | 40 (6) | 9.6 (6.9–13.0) |
*MRSA, methicillin-resistant Staphylococcus aureus; CI, confidence interval.
Page created: December 10, 2010
Page updated: December 10, 2010
Page reviewed: December 10, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.